West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110,200 | 97,100 | 67,500 | 65,900 | 83,100 |
| Receivables | 126,400 | 142,800 | 145,700 | 146,600 | 138,700 |
| Inventories | 147,000 | 148,400 | 143,300 | 144,800 | 129,200 |
| Income taxes - deferred | 10,500 | 8,300 | 7,400 | 7,300 | 7,800 |
| Other current assets | 42,500 | 44,600 | 40,000 | 40,300 | 38,400 |
| TOTAL | $436,600 | $441,200 | $403,900 | $404,900 | $397,200 |
| Non-Current Assets | |||||
| PPE Net | 554,800 | 556,700 | 532,500 | 556,200 | 577,100 |
| Investments And Advances | 48,200 | 43,800 | 40,100 | 40,200 | 38,200 |
| Intangibles | 167,600 | 169,700 | 160,400 | 166,300 | 169,800 |
| Other Non-Current Assets | 87,100 | 88,200 | 85,200 | 86,000 | 88,700 |
| TOTAL | $857,700 | $858,400 | $818,200 | $848,700 | $873,800 |
| Total Assets | $1,294,300 | $1,299,600 | $1,222,100 | $1,253,600 | $1,271,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 63,200 | 56,300 | 61,400 | 66,400 | 68,400 |
| Accrued Expenses | 48,300 | 51,100 | 42,000 | 42,900 | 46,800 |
| Other current liabilities | 42,900 | 28,400 | 36,600 | 35,700 | 41,600 |
| TOTAL | $169,700 | $158,200 | $158,600 | $183,800 | $171,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 358,100 | 369,300 | 356,800 | 348,300 | 379,100 |
| aiOther Non-Current Liabilities | 120,800 | 116,900 | 115,500 | 120,200 | 118,800 |
| TOTAL | $498,900 | $509,300 | $492,500 | $490,100 | $520,800 |
| Total Liabilities | $668,600 | $667,500 | $651,100 | $673,900 | $691,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,692 | 66,596 | 66,551 | 66,516 | 66,207 |
| Common Shares | 8,600 | 8,600 | 8,600 | 8,600 | 8,600 |
| Retained earnings | 612,600 | 618,000 | 600,300 | 583,800 | 569,400 |
| Other shareholders' equity | -30,800 | -28,200 | -65,400 | -37,200 | -19,800 |
| TOTAL | $625,700 | $632,100 | $571,000 | $579,700 | $579,100 |
| Total Liabilities And Equity | $1,294,300 | $1,299,600 | $1,222,100 | $1,253,600 | $1,271,000 |